Familial Hypercholesterolaemia clinical trials

Explore recruiting familial hypercholesterolaemia clinical trials.

Recruiting familial hypercholesterolaemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Familial Hypercholesterolaemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Reassessment of statin-associated musscle symptoms in adults with familial hypercholesterolemia: A phase IV randomized double-blinded n-of-1 crossover trial including periods with atorvastatin, placebo and no study treatment

Norway

Therapeutic use (Phase IV) EU CTIS Study details

An open-label, single arm, multicenter extension study to evaluate long-term safety and tolerability of inclisiran in participants with heterozygous or homozygous familial hypercholesterolemia who have completed the adolescent ORION-16 or ORION-13 studies (VICTORION-PEDS-OLE)

Germany, Spain, Hungary, Norway, Netherlands, Poland +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Effect of AZD0780 on Low Density Lipoprotein Cholesterol in Patients With Heterozygous Familial Hypercholesterolaemia

Slovakia, Bulgaria, Spain, Finland, Sweden, France +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Comparison of inclisiran or alirocumab to standard therapy in pediatric heterozygous familial hypercholesterolemia (HeFH) – the head-to-head PICOLO-FH clinical trial

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Study 1002-041: An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Bempedoic Acid in Pediatric Patients (6 to 17 Years of Age) with Heterozygous Familial Hypercholesterolemia

Germany, Netherlands, Denmark, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Familial Hypercholesterolaemia trials by city

Familial Hypercholesterolaemia in Toronto Familial Hypercholesterolaemia in Vancouver Familial Hypercholesterolaemia in Montreal Familial Hypercholesterolaemia in Calgary Familial Hypercholesterolaemia in Edmonton Familial Hypercholesterolaemia in Ottawa Familial Hypercholesterolaemia in Winnipeg Familial Hypercholesterolaemia in Quebec City Familial Hypercholesterolaemia in Hamilton Familial Hypercholesterolaemia in Kitchener Familial Hypercholesterolaemia in London Familial Hypercholesterolaemia in Halifax Familial Hypercholesterolaemia in New York Familial Hypercholesterolaemia in Los Angeles Familial Hypercholesterolaemia in Chicago Familial Hypercholesterolaemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease